RBC Capital Keeps Their Buy Rating on Bloom Energy (BE)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Modi is a 2-star analyst with an average return of 0.5% and a 51.40% success rate. Modi covers the Consumer Defensive sector, focusing on stocks such as Constellation Brands, Procter & Gamble, and Clorox.
In addition to RBC Capital, Bloom Energy also received a Buy from J.P. Morgan's Mark Strouse in a report issued on July 9. However, on June 29, BMO Capital maintained a Hold rating on Bloom Energy (NYSE: BE).
BE market cap is currently $6.67B and has a P/E ratio of -307.74.
Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BE in relation to earlier this year. Last month, Maciej Kurzymski, the See Remarks of BE sold 8,733.00 shares for a total of $199,025.07.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
43 minutes ago
- Globe and Mail
This Stock Has Increased 4,720%: Here's Why It's Still a Buy
Key Points Johnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the company's success is its ability to innovate. Despite various challenges, the drugmaker's strong business and dividend program make it attractive. 10 stocks we like better than Johnson & Johnson › Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an excellent company can yield substantial returns, especially when dividends are reinvested. Case in point: Shares of Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare companies, have increased by 4,720% over the past few decades. The stock may have garnered more headlines due to various legal challenges over the past few years, but it remains an excellent long-term option, especially for income seekers. Here's the rundown. JNJ Total Return Level data by YCharts. The secret to Johnson & Johnson's success Medical care is always in high demand: So long as we get sick, this is one sector that will never disappear. However, specific companies in the industry can cease to exist. One reason they do is their failure to innovate. Even if healthcare never sleeps, it does evolve, and it's critical for companies aiming to be successful over the long run to keep pace with that evolution. Johnson & Johnson has done that admirably over the years. Consider its pharmaceutical segment. Last year, the drugmaker had more than 10 medicines that each generated over $1 billion in sales. In 2014, Johnson & Johnson also had more than 10 drugs that were blockbusters. Some of them were the same as last year's, but some weren't -- because the company has developed and marketed newer therapies over the past decade that have replaced older ones. In a decade, Johnson & Johnson's lineup of approved products will look different yet again. However, one thing won't change: It will still have many drugs that reach the $1 billion annual sales mark. J&J has more than 100 programs in its pipeline. True, many of those are for therapies seeking label expansions. But the company also has some brand-new clinical compounds, at least some of which will make it through the rigorous clinical-trial testing phases and go on to be massively successful. And we haven't even mentioned Johnson & Johnson's medtech business, where it markets a range of medical devices across several major therapeutic areas. Its operations are well diversified in the healthcare sector. That, combined with the company's innovative qualities, makes it likely to remain a leader in healthcare for a long time. Johnson & Johnson can overcome its challenges Johnson & Johnson has encountered some headwinds in recent years. It's facing thousands of lawsuits from plaintiffs who allege that its talc-based products gave them cancer. The company has attempted to resolve these issues through various settlement proposals, but so far, to no avail. These legal battles are worth monitoring, but the stock is attractive despite them. The company is not at serious risk of bankruptcy. That's why it still has an AAA credit rating, which is even higher than that of the U.S. government. Several judges have shot down its attempts to settle these lawsuits via a bankruptcy maneuver through a subsidiary, partly because of the company's underlying financial strength. While it's hard to know how this saga will end, my view is that Johnson & Johnson will continue performing well long after the dust settles. Here's another potential challenge Johnson & Johnson faces: Some of its therapies will generate significantly less revenue in the next few years, due to either patent cliffs or Medicare price negotiations in the U.S. Here again, J&J can handle this threat. The company's innovative ability is the best way to overcome this problem. The healthcare specialist can also count on its medtech unit to pick up some of the slack. One attractive opportunity in this segment is within the robotic-assisted surgery (RAS) niche. Johnson & Johnson is developing its Ottava RAS system, which should grant it plenty of long-term revenue opportunities and help it navigate patent cliffs. Of course, we can't talk about J&J without mentioning its dividend. The company has increased its payouts for 62 consecutive years, which makes it a Dividend King. This streak highlights, once again, how strong Johnson & Johnson's business is -- most corporations don't even last six decades, let alone pay dividends for that long. The stock is an excellent pick for long-term, income-oriented investors. Should you invest $1,000 in Johnson & Johnson right now? Before you buy stock in Johnson & Johnson, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Johnson & Johnson wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025
Globe and Mail
an hour ago
- Globe and Mail
Should You Invest $10,000 in Nvidia Stock Right Now?
Key Points Data center capital expenditures are reaching record highs. A significant portion of data center spending is allocated to equipping them with Nvidia GPUs. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) has been an excellent stock to own over the past few years, as the company has gained the status of having the largest market capitalization in the world. However, given the stock's impressive performance, many investors are likely wondering if there's still room for Nvidia to run. After all, the stock has risen by around 1,000% since the start of 2023. Is investing $10,000 in Nvidia right now a waste of money? Or is it a brilliant investment decision? I think the answer is clear, and there's one long-term trend that guides that conclusion. Nvidia has risen alongside AI demand Nvidia manufactures graphics processing units (GPUs), which are specialized computing devices that can perform multiple calculations in parallel. GPUs were originally designed to process gaming graphics -- some of the most arduous workloads computers saw almost three decades ago. They excelled in this area, but quickly found other uses such as engineering simulations, cryptocurrency mining, and drug discovery. Still, their biggest use case has just emerged: AI training. GPUs can handle a wide range of workloads and process them efficiently, making them ideal for feeding various datasets to train an AI model. Additionally, GPUs can be connected in clusters to amplify computing power, a strategy that AI hyperscalers have taken to the extreme by building AI training clusters with 100,000 or more GPUs. Nvidia dominates the GPU market with a 90% market share. This dominance has enabled it to charge a premium price for its product, resulting in profits that far outpace revenue growth. NVDA Revenue (TTM) data by YCharts This combination has enabled Nvidia's stock to soar since the AI revolution began in 2023. But is there more upside? Data center capital expenditures will push Nvidia's stock higher We've yet to scratch the surface of what an AI-first business environment looks like. As a result, the AI hyperscalers are building data centers at an unprecedented rate to meet the demand. Every AI hyperscaler has announced record capital expenditures for 2025, with most of that money being allocated to data centers. Although this spending may be earmarked for 2025, building a data center is a multiyear process, so we can expect record capital expenditures to continue for the next few years. This directly aligns with a third-party market study that Nvidia cited during its 2025 GTC event, which projected global capital expenditures on data centers to rise from $400 billion in 2024 to $1 trillion by 2028. In 2024, Nvidia generated $115 billion in revenue from its data center division, which earns it a healthy slice of the data center capital expenditure pie. If Nvidia can maintain its market share within the data center space, it could generate nearly $300 billion in revenue from data centers alone. Considering that Nvidia's trailing-12-month revenue total is just shy of $150 billion, this indicates a significant amount of upside remains in Nvidia's stock. Although it has been a top performer for multiple years, Nvidia has earned that title. Additionally, there is plenty of growth left in the pipeline to continue fueling Nvidia's rise. While it is unlikely to return another 1,000% from here, I believe there is still sufficient growth potential in the data center space, allowing for market-beating returns to be achieved. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025
Globe and Mail
an hour ago
- Globe and Mail
The Median Retirement Savings for American Households is $87,000. Here Are 5 Incredible Investments to Buy Now and Hold for Decades.
Key Points Americans aren't saving enough for retirement. Here are three exchange-traded funds to build your nest egg around. Complement them with top-notch individual stocks, such as this AI leader, plus a cryptocurrency to protect against inflation. 10 stocks we like better than Vanguard S&P 500 ETF › Despite the remarkable U.S. economy, Americans are falling dramatically short of their retirement goals. According to research by The Motley Fool, most Americans are saving and investing in a retirement account, but just 34% believe that they're on track to hit their goals. The study found that the median U.S. household has just $87,000 saved, with the typical household reaching a peak of around $200,000 between the ages of 65 and 74. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » If you're still working, a diversified investment portfolio can help you change your financial trajectory, even if you're starting later than you had hoped to. Here are five incredible investments to consider for your long-term portfolio that could help move the needle for your retirement over the coming decades. Consider buying and holding them today. 1. An ETF you can build your retirement around For quick and straightforward portfolio diversification, consider exchange-traded funds (ETFs). These are collections of individual stocks that trade under a single ticker symbol. Among them, it's hard to beat the Vanguard S&P 500 ETF (NYSEMKT: VOO). This ETF tracks the S&P 500, an index of 500 prominent U.S. companies. Investing in this ETF provides exposure to various market sectors and industries. The S&P 500 adheres to strict selection criteria that help maintain its quality. Its system works. The S&P 500 is arguably the most proven wealth-building machine of all time, making it a no-brainer to include in your retirement portfolio. 2. Casting a wider net, this ETF offers instant diversification Diversifying your portfolio goes beyond the companies and industries you invest in. It also includes geographic markets. Therefore, you should consider an ETF such as the Vanguard Total World Stock ETF (NYSEMKT: VT), a global stock market ETF with over 9,700 individual stocks from almost every industry across various countries. It represents an investment in the broader global economy, which is crucial because there may be times when the U.S. stock market stumbles or lags behind other countries. This ETF pairs nicely with the Vanguard S&P 500 ETF as a foundation for your nest egg that should last as long as you need it to. 3. This innovation ETF should also help grow your nest egg Now, it's time to look to growth to help your money compound over the coming decades. Consider the Invesco QQQ Trust (NASDAQ: QQQ) a fantastic starting point. This ETF tracks the Nasdaq-100, an index with a heavy focus on technology stocks. It provides abundant exposure to the "Magnificent Seven" stocks, which lead the way in artificial intelligence (AI), cloud computing, e-commerce, digital advertising, and other high-growth industries. This fund can be more volatile, but it has outperformed the S&P 500 over its lifetime. That may not always be the case, but the world is becoming increasingly tech driven, making the Invesco QQQ an excellent way to bet on innovation as a whole. 4. A leading AI stock that could boost your portfolio's results It's fine to sprinkle in some individual stocks after you have built a foundation for your portfolio. AI could create trillions of dollars in economic value down the road, making it perhaps the most important growth story you can invest in right now. Nvidia (NASDAQ: NVDA) has already established itself as an AI powerhouse. It's the dominant leader in supplying chips used to train and run AI models in data centers. Nvidia continues to grow as companies invest billions to build data centers, and experts predict that these expenditures could amount to trillions of dollars over the coming years. Beyond that, Nvidia could also play a part in emerging AI-driven technologies, such as autonomous vehicles and humanoid robotics. Nvidia is a total package that should continue to thrive, considering the AI era is only just beginning. 5. Hedge for inflation with the flagship cryptocurrency President Donald Trump recently signed his "One Big Beautiful Bill" into law, officially raising America's debt ceiling. It's another sign that the U.S. government figures to continue spending to support its interests, a long-standing pattern that has steadily increased the country's debt. As a result, it may be worthwhile to include some anti-inflationary investments in your portfolio. Bitcoin (CRYPTO: BTC) is the largest and most prominent cryptocurrency. Its status and capped maximum supply have resulted in staggering price appreciation that has easily outpaced the stock market for years. Alternatively, if you're skeptical of cryptocurrencies, consider investing in gold, which remains a popular hedge against inflation to this day. Either way, having some anti-inflationary investments is yet another way to cover all your bases and mitigate risk. Should you invest $1,000 in Vanguard S&P 500 ETF right now? Before you buy stock in Vanguard S&P 500 ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard S&P 500 ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025
